NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

中國的帶狀皰疹疫苗市場分析(2021年∼2025年)

Investigation Report on China's Shingles Vaccine Market 2021-2025

出版商 China Research and Intelligence 商品編碼 1006919
出版日期 內容資訊 英文 40 Pages
商品交期: 最快1-2個工作天內
價格
中國的帶狀皰疹疫苗市場分析(2021年∼2025年) Investigation Report on China's Shingles Vaccine Market 2021-2025
出版日期: 2021年05月21日內容資訊: 英文 40 Pages
簡介

Glaxo SmithKline所開發的帶狀皰疹疫苗 "SHINGRIX" ,2020年中國首次承認。重組的帶狀皰疹疫苗的對象是50歲以上的成人。中國的帶狀皰疹疫苗市場上,至2020年Glaxo SmithKline Biologicals成為國內唯一的製藥企業。2020年進入到中國市場以來,帶狀皰疹疫苗的年度銷售額達到200萬元,年度銷售數達到了1,745次份。因此,今後發展預測極為良好。預計從2021年到2025年,帶狀皰疹疫苗市場擴大,其銷售量也增加。

本報告提供中國的帶狀皰疹疫苗市場相關調查,產品概要,新型冠狀病毒感染疾病(COVID-19)的影響,中國整體及各地區的銷售趨勢,製藥企業的市場佔有率,銷售額及銷售額數,價格趨勢,市場預測,市場成長要素,市場機會,課題等資料彙整。

目錄

第1章 帶狀皰疹疫苗概要

  • 帶狀皰疹疫苗的適應症
  • 中國的帶狀皰疹疫苗的開發
  • 中國的帶狀皰疹疫苗的政府核准
  • 新型冠狀病毒感染疾病(COVID-19)的銷售額的影響

第2章 中國的帶狀皰疹疫苗的銷售趨勢(2020年)

  • 帶狀皰疹疫苗的銷售額
    • 銷售額:全體
    • 銷售額:各地區
  • 帶狀皰疹疫苗的銷售額數
    • 銷售額數:全體
    • 銷售額數:各地區
  • 帶狀皰疹疫苗的銷售趨勢:各劑型
    • 注射劑
    • 其他劑型

第3章 中國的主要帶狀皰疹疫苗製造企業(2020年)

  • 主要企業的市場佔有率
    • 銷售額
    • 銷售額數
  • Glaxo SmithKline Biologicals
    • 企業簡介
    • SHINGRIX的中國國內的銷售額

第4章 中國的帶狀皰疹疫苗的價格(2020年∼2021年)

  • Glaxo SmithKline Biologics(SHINGRIX)

第5章 中國的帶狀皰疹疫苗市場預測(2021年∼2025年)

  • 市場發展的影響要素
    • 新型冠狀病毒感染疾病(COVID-19)的影響
    • 市場成長要素和機會
    • 市場威脅與課題
  • 市場規模的預測
  • 市場趨勢的預測
目錄
Product Code: 2105487

The trade name of Shingles Vaccine is SHINGRIX, which was developed by GlaxoSmithKline. Its product was firstly approved in China in 2020. Recombinant zoster vaccine is suitable for adults aged 50 years and over to protect against shingles (herpes zoster). The recombinant zoster vaccine has been listed in the Chinese market. By 2020, Glaxo SmithKline Biologicals is the only manufacturer in the Chinese Shingles Vaccine market.

According to CRI's market research, since Shingles Vaccine entered the Chinese market in 2020, its annual sales value reached CNY2 million, and its annual sales volume reached 1,745 doses. Therefore, the development prospects are quite good.

According to CRI analysis, from 2021 to 2025, as Shingles Vaccine market expands, its sales will continue to grow. Compared with Merck's Zostavax, SHINGRIX has better preventive effects and faster replacement velocity. Therefore, as the market share of Shingles Vaccine will gradually increase, and sales and sales volume will also increase.

Topics Covered:

  • The impact of COVID-19 on China's Shingles Vaccine market
  • Sales value of China's Shingles Vaccine 2016-2020
  • Competitive landscape of China's Shingles Vaccine market
  • Prices of Shingles Vaccine in China
  • Prices of Shingles Vaccine in China by regions and manufacturers
  • Analysis on factors affecting the development of China's Shingles Vaccine market
  • Prospect of China's Shingles Vaccine market from 2021 to 2025

Table of Contents

1 Relevant Concepts of Shingles Vaccine

  • 1.1 Indications for Shingles Vaccine
  • 1.2 Development of Shingles Vaccine in China
  • 1.3 Governmental Approval of Shingles Vaccine in China
  • 1.4 The Impact of COVID-19 on Shingles Vaccine sales in China

2 Sales of Shingles Vaccine in China in 2020

  • 2.1 Sales Value of Shingles Vaccine
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Regions
  • 2.2 Sales Volume of Shingles Vaccine
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Regions
  • 2.3 Sales of Shingles Vaccine by Dosage Form in China in 2020
    • 2.3.1 Injection
    • 2.3.2 Analysis of Other Dosage Forms

3 Analysis of Major Shingles Vaccine Manufacturers in China in 2020

  • 3.1 Analysis of Market Share of Major Shingles Vaccine Manufacturers
    • 3.1.1 Investigation on Market Share by Sales Value
    • 3.1.2 Investigation on Market Share by Sales volume
  • 3.2 Glaxo SmithKline Biologicals
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of SHINGRIX (Glaxo SmithKline Biologicals' Shingles Vaccine) in China

4 Prices of Shingles Vaccine for Different Manufacturers in China, 2020-2021

  • 4.1 Glaxo SmithKline Biologicals (SHINGRIX)

5 Prospect of Chinese Shingles Vaccine drug Market, 2021-2025

  • 5.1 Influential Factors of Chinese Shingles Vaccine Market Development
    • 5.1.1 The Impact of COVID-19 on Chinese Shingles Vaccine Market
    • 5.1.2 Market Drivers and Opportunities
    • 5.1.3 Market Threats and Challenges
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

List of Charts

  • Chart Patent Information About Shingles Vaccine Injection Registration in China
  • Chart Sales Value of Shingles Vaccine Injection over the World
  • Chart Sales Value of Shingles Vaccine Injection in China in 2020
  • Chart Sales Value of Shingles Vaccine Injection in China by Regions in 2020
  • Chart Sales Volume of Shingles Vaccine Injection in China in 2020
  • Chart Sales Volume of Shingles Vaccine Injection in China by Regions in 2020
  • Chart Market Share by Sales Value of Top Shingles Vaccine Manufacturers in China in 2020
  • Chart Sales Value and Volume of SHINGRIX in China in 2020
  • Chart Referential Prices of SHINGRIX in China by Regions, 2020-2021
  • Chart Forecast on Sales Value of Shingles Vaccine in China, 2021-2025
  • Chart Forecast on Sales Volume of Shingles Vaccine in China, 2021-2025